1 |
Bristol-Myers v. Danbury Pharmacal, et al |
3:01-cv-00304 |
D.Conn. |
|
|
|
|
2 |
Platt v. Bayer Corporation, et al |
2:01-cv-02155 |
W.D.Tenn. |
|
|
|
|
3 |
Pfizer Inc. et al v. Watson Pharmaceuticals, Inc. et al |
1:04-cv-05212 |
S.D.N.Y. |
|
|
|
|
4 |
Pfizer Inc. et al v. Watson Pharmaceuticals, Inc. et al |
1:04-cv-05212 |
S.D.N.Y. |
|
|
|
|
5 |
Pfizer Inc. et al v. Watson Pharmaceuticals, Inc. et al |
1:04-cv-05212 |
S.D.N.Y. |
|
|
|
|
6 |
PFIZER INC. v. WATSON PHARMACEUTICALS, INC. |
2:04-cv-04789 |
D.N.J. |
|
|
|
|
7 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
8 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
9 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
10 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
11 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
12 |
Dey v. Watson Pharmaceuticals Inc |
5:06-cv-00395 |
C.D.Cal. |
|
|
|
|
13 |
Shire Laboratories Inc. v. Andrx Pharmaceutical, L.L.C. et al |
0:06-cv-61699 |
S.D.Fla. |
|
|
|
|
14 |
Shire Laboratories Inc. v. Andrx Pharmaceuticals, LLC et al |
1:07-cv-22201 |
S.D.Fla. |
|
|
|
|
15 |
Shire Laboratories Inc. v. Andrx Pharmaceuticals, LLC et al |
1:07-cv-22201 |
S.D.Fla. |
|
|
|
|
16 |
Wyeth v. Watson Laboratories Inc. et al |
1:08-cv-00145 |
D.Del. |
|
|
|
|
17 |
Cephalon Inc. et al v. Watson Pharmaceuticals Inc. et al |
1:08-cv-00330 |
D.Del. |
|
|
|
|
18 |
Cephalon Inc. et al v. Watson Pharmaceuticals Inc. et al |
1:08-cv-00330 |
D.Del. |
|
|
|
|
19 |
Reckitt Benckiser Inc. v. Watson Laboratories, Inc. - Florida et al |
0:09-cv-60609 |
S.D.Fla. |
|
|
|
|
20 |
Reckitt Benckiser Inc. v. Watson Laboratories, Inc. - Florida et al |
0:09-cv-60852 |
S.D.Fla. |
|
|
|
|
21 |
Takeda Pharmaceutical Company LTD. et al v. Teva Pharmaceuticals USA Inc. et al |
1:09-cv-00841 |
D.Del. |
|
|
|
|
22 |
Takeda Pharmaceutical Company LTD. et al v. Teva Pharmaceuticals USA Inc. et al |
1:09-cv-00841 |
D.Del. |
|
|
|
|
23 |
Takeda Pharmaceutical Company LTD. et al v. Teva Pharmaceuticals USA Inc. et al |
1:09-cv-00841 |
D.Del. |
|
|
|
|
24 |
TEVA WOMEN'S HEALTH, INC. v. LUPIN, LTD. et al |
2:10-cv-00080 |
D.N.J. |
|
|
|
|
25 |
Biovail Laboratories International SRL v. Watson Pharmaceuticals, Inc. et al |
1:10-cv-21241 |
S.D.Fla. |
|
|
|
|
26 |
Abbott Laboratories et al v. Watson Laboratories, Inc.-Florida et al |
0:10-cv-60677 |
S.D.Fla. |
|
|
|
|
27 |
Abbott Laboratories et al v. Watson Laboratories, Inc.-Florida et al |
0:10-cv-60677 |
S.D.Fla. |
|
|
|
|
28 |
Allergan Inc. et al v. Watson Laboratories Inc.-Florida |
1:10-cv-00852 |
D.Del. |
|
|
|
|
29 |
Allergan Inc. et al v. Watson Laboratories Inc.-Florida |
1:10-cv-00852 |
D.Del. |
|
|
|
|
30 |
Allergan Inc. et al v. Watson Laboratories Inc.-Florida |
1:10-cv-00852 |
D.Del. |
|
|
|
|
31 |
Allergan Inc. et al v. Watson Laboratories Inc.-Florida |
1:10-cv-00852 |
D.Del. |
|
|
|
|
32 |
Daiichi Sankyo Inc. et al v. Watson Pharmaceuticals Inc. et al |
1:11-cv-00074 |
D.Del. |
|
|
|
|
33 |
Daiichi Sankyo Inc. et al v. Watson Pharmaceuticals Inc. et al |
1:11-cv-00074 |
D.Del. |
|
|
|
|
34 |
Alcon Pharmaceuticals Ltd et al v. Watson Laboratories Inc. et al |
1:11-cv-00293 |
D.Del. |
|
|
|
|
35 |
Alcon Pharmaceuticals Ltd et al v. Watson Laboratories Inc. et al |
1:11-cv-00293 |
D.Del. |
|
|
|
|
36 |
Momenta Pharmaceuticals, Inc. et al v. Amphastar Pharmaceuticals, Inc. et al |
1:11-cv-11681 |
D.Mass. |
|
|
|
|
37 |
Momenta Pharmaceuticals, Inc. et al v. Amphastar Pharmaceuticals, Inc. et al |
1:11-cv-11681 |
D.Mass. |
|
|
|
|
38 |
Merck & Cie et al v. Watson Laboratories Inc. |
1:12-cv-00161 |
D.Del. |
|
|
|
|
39 |
Merck & Cie et al v. Watson Laboratories Inc. |
1:12-cv-00161 |
D.Del. |
|
|
|
|
40 |
Merck & Cie et al v. Watson Laboratories Inc. |
1:12-cv-00161 |
D.Del. |
|
|
|
|
41 |
Avanir Pharmaceuticals Inc. et al v. Watson Pharmaceuticals Inc. et al |
1:12-cv-00258 |
D.Del. |
|
- 6 University/Government/Non-profit
- 8 Product company
|
|
|
42 |
Avanir Pharmaceuticals Inc. et al v. Watson Pharmaceuticals Inc. et al |
1:12-cv-00258 |
D.Del. |
|
- 6 University/Government/Non-profit
- 8 Product company
|
|
|
43 |
Avanir Pharmaceuticals Inc. et al v. Watson Pharmaceuticals Inc. et al |
1:12-cv-00258 |
D.Del. |
|
- 6 University/Government/Non-profit
- 8 Product company
|
|
|
44 |
DEPOMED, INC. v. ACTAVIS ELIZABETH LLC et al |
3:12-cv-01358 |
D.N.J. |
|
|
|
|
45 |
Depomed Inc. et al v. Watson Laboratories Inc. Florida et al |
1:12-cv-00492 |
D.Del. |
|
|
|
|
46 |
Depomed Inc. et al v. Watson Laboratories Inc. Florida et al |
1:12-cv-00492 |
D.Del. |
|
|
|
|
47 |
Depomed Inc. et al v. Watson Laboratories Inc. Florida et al |
1:12-cv-00492 |
D.Del. |
|
|
|
|
48 |
AUXILIUM PHARMACEUTICALS, INC. et al v. WATSON LABORATORIES, INC. (NV) et al |
2:12-cv-03084 |
D.N.J. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
49 |
AUXILIUM PHARMACEUTICALS, INC. et al v. WATSON LABORATORIES, INC. (NV) et al |
2:12-cv-03084 |
D.N.J. |
|
- 8 Product company
- 12 IP subsidiary of product company
|
|
|
50 |
CELGENE CORPORATION v. NATCO PHARMA LIMITED et al |
2:12-cv-04571 |
D.N.J. |
|
|
|
|